FTC Wants Access To Boehringer Docs In Pay-For-Delay Probe

Law360, New York (September 12, 2013, 9:24 PM EDT) -- The Federal Trade Commission told the D.C. Circuit on Wednesday that it should force Boehringer Ingelheim Pharmaceuticals Inc. to turn over documents about a $100 million drug co-promotion deal with Barr Pharmaceuticals Inc., saying the information could indicate an unlawful pay-for-delay agreement.

The documents cover financial analyses of both the co-promotion deal and an agreement from Barr to drop patents challenges to two of Boehringer’s branded drugs. They are crucial to the FTC's investigation into whether Boehringer used the agreements to compensate Barr for delaying competitive...
To view the full article, register now.